Collection: Products

Ozempic (semaglutide) solution for injection in pre-filled pen – type 2 diabetes treatment

Pharmacology: GLP-1 receptor agonist. Glucose-dependent stimulation of insulin secretion and suppression of glucagon secretion.

Licensed indication: Insufficiently controlled T2DM in adults, as an adjunct to diet and exercise: as monotherapy where metformin is not tolerated or contraindicated, or in addition to other medicinal products for diabetes. Not licensed for weight management.

Report adverse reactions via the MHRA Yellow Card scheme.

Before first use, store in a refrigerator (2–8 °C), away from the cooling element. Do not freeze. After first use, store below 30°C or in a refrigerator for 6 weeks. Keep the pen cap on to protect from light.

Ozempic (semaglutide) solution for injection in pre-filled pen – type 2 diabetes treatment

Pharmacology: GLP-1 receptor agonist. Glucose-dependent stimulation of insulin secretion and suppression of glucagon secretion.

Licensed indication: Insufficiently controlled T2DM in adults, as an adjunct to diet and exercise: as monotherapy where metformin is not tolerated or contraindicated, or in addition to other medicinal products for diabetes. Not licensed for weight management.

Report adverse reactions via the MHRA Yellow Card scheme.

Before first use, store in a refrigerator (2–8 °C), away from the cooling element. Do not freeze. After first use, store below 30°C or in a refrigerator for 6 weeks. Keep the pen cap on to protect from light.

Ozempic (semaglutide) solution for injection in pre-filled pen – type 2 diabetes treatment

Pharmacology: GLP-1 receptor agonist. Glucose-dependent stimulation of insulin secretion and suppression of glucagon secretion.

Licensed indication: Insufficiently controlled T2DM in adults, as an adjunct to diet and exercise: as monotherapy where metformin is not tolerated or contraindicated, or in addition to other medicinal products for diabetes. Not licensed for weight management.

Report adverse reactions via the MHRA Yellow Card scheme.

Before first use, store in a refrigerator (2–8 °C), away from the cooling element. Do not freeze. After first use, store below 30°C or in a refrigerator for 6 weeks. Keep the pen cap on to protect from light.

The device is intended to be used by a registered healthcare professional and intended to be used in adult patients (over 18) whom are not pregnant or breast-feeding and are deemed appropriate for treatment by the healthcare professional. PERFECTHA LIDOCAINE is a sterile cross-linked hyaluronic acid gel of non-animal origin with 0.3% (w/w) lidocaine hydrochloride. The gel is supplied in a pre-filled, ready-to-use, single-use syringe. Each carton contains single-use accessories to be used with the product supplied. PERFECTHA LIDOCAINE is an implantable, resorbable dermal filler. The effects of PERFECTHA LIDOCAINE are immediately apparent, how long it lasts depends on the volume and depth of injection, the healthcare professional's injection technique and the patient's lifestyle. Treatment effects have variable duration** dependant on the product variant used, healthcare professional injection technique, patient lifestyle and metabolic rate. **studies have shown effects from 6-18 months dependant on product variant

The device is intended to be used by a registered healthcare professional and intended to be used in adult patients (over 18) whom are not pregnant or breast-feeding and are deemed appropriate for treatment by the healthcare professional. PERFECTHA LIDOCAINE is a sterile cross-linked hyaluronic acid gel of non-animal origin with 0.3% (w/w) lidocaine hydrochloride. The gel is supplied in a pre-filled, ready-to-use, single-use syringe. Each carton contains single-use accessories to be used with the product supplied. PERFECTHA LIDOCAINE is an implantable, resorbable dermal filler. The effects of PERFECTHA LIDOCAINE are immediately apparent, how long it lasts depends on the volume and depth of injection, the healthcare professional's injection technique and the patient's lifestyle. Treatment effects have variable duration** dependant on the product variant used, healthcare professional injection technique, patient lifestyle and metabolic rate. **studies have shown effects from 6-18 months dependant on product variant

Comprehensive improvement addressing skin concerns such as acne scars and management of striae, as well as targeted enhancement for overall skin quality (e.g. improving skin firmness, elasticity and tone) Skin Enhancement Technique (SET) to generates a synergistic effect and helps prepare the skin before other aesthetic procedures: Toxin, PRP, filler, peeling, needling and surgery.

Created for the eye contour, and other delicate areas of the face to relieve the look of tired under eyes while reducing the appearance of fine lines over the recommended course of treatment.

Supports revitalisation of the hair follicles resulting in promotion and acceleration of the hair growth.

A combined formulation determines a synergic action to significantly improve skin hydration in association with fostering fibroblasts resulting in the restauration or/and improvement of the skin elasticity, trophism, firmness, tone and appearance. Remodelling striae distensae and depressed scars, as part of personalised treatment protocols.